CD19 B cell repopulation after ocrelizumab, alemtuzumab and cladribine: Implications for SARS-CoV-2 vaccinations in multiple sclerosis

Overview of attention for article published in Multiple Sclerosis and Related Disorders, January 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (93rd percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news: 1 news outlet
blogs: 1 blog

twitter: 20 X users

Citations

dimensions_citation: 18 Dimensions

Readers on

mendeley: 49 Mendeley

Summary News Blogs X Dimensions citations

So far, Altmetric has seen 1 news story.

CD19 B cell repopulation after ocrelizumab, alemtuzumab and cladribine: Implications for SARS-CoV-2 vaccinations in multiple sclerosis

Doc Wire News, 13 Dec 2021

This article was originally published here Mult Scler Relat Disord. 2021 Dec 4;57:103448.

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.